Vermillion PE Ratio 2006-2019 | VRML

Current and historical p/e ratio for Vermillion (VRML) from 2006 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Vermillion PE ratio as of August 16, 2019 is 0.00.
Vermillion PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-08-16 0.55 0.00
2019-03-31 1.15 $-0.17 0.00
2018-12-31 0.30 $-0.17 0.00
2018-09-30 0.71 $-0.18 0.00
2018-06-30 0.78 $-0.20 0.00
2018-03-31 1.36 $-0.20 0.00
2017-12-31 1.93 $-0.20 0.00
2017-09-30 1.80 $-0.20 0.00
2017-06-30 1.84 $-0.21 0.00
2017-03-31 2.09 $-0.24 0.00
2016-12-31 0.95 $-0.28 0.00
2016-09-30 1.30 $-0.33 0.00
2016-06-30 1.11 $-0.36 0.00
2016-03-31 1.47 $-0.40 0.00
2015-12-31 1.80 $-0.41 0.00
2015-09-30 2.00 $-0.42 0.00
2015-06-30 2.07 $-0.48 0.00
2015-03-31 1.77 $-0.52 0.00
2014-12-31 1.99 $-0.53 0.00
2014-09-30 1.79 $-0.49 0.00
2014-06-30 2.58 $-0.43 0.00
2014-03-31 2.95 $-0.39 0.00
2013-12-31 2.36 $-0.45 0.00
2013-09-30 2.57 $-0.47 0.00
2013-06-30 2.67 $-0.50 0.00
2013-03-31 1.20 $-0.52 0.00
2012-12-31 1.32 $-0.47 0.00
2012-09-30 1.69 $-0.59 0.00
2012-06-30 2.25 $-0.77 0.00
2012-03-31 2.02 $-1.03 0.00
2011-12-31 1.17 $-1.25 0.00
2011-09-30 2.61 $-1.42 0.00
2011-06-30 4.09 $-1.37 0.00
2011-03-31 4.60 $-1.05 0.00
2010-12-31 7.52 $-1.85 0.00
2010-09-30 5.52 $-2.33 0.00
2010-06-30 12.19 $-3.79 0.00
2010-03-31 28.75 $-4.00 0.00
2009-12-31 27.45 $-3.30 0.00
2009-09-30 13.50 $-2.44 0.00
2009-06-30 0.04 $-0.72 0.00
2009-03-31 0.30 $-0.44 0.00
2008-12-31 0.27 0 0.00
2008-09-30 1.00 0 0.00
2008-06-30 2.27 0 0.00
2008-03-31 3.16 0 0.00
2007-12-31 8.10 0 0.00
2007-09-30 10.00 0 0.00
2007-06-30 9.70 0 0.00
2007-03-31 14.00 0 0.00
2006-12-31 8.90 0 0.00
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.052B $0.003B
Vermillion, Inc. is engaged in the discovery, development and commercialization of novel diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. The Company has diagnostic programs in oncology, hematology, cardiology and women's health. Its tests are intended to guide decisions regarding patient treatment, which may include decisions to refer patients to specialists, to perform additional testing, or to assist in the selection of therapy. Vermillion also intends to address clinical questions related to early disease detection, treatment response, monitoring of disease progression, prognosis and others. Its lead product includes the OVA1 ovarian tumor triage test, which addresses presurgical identification of women who are at high risk of having a malignant ovarian tumor. In addition to the OVA1 Test, Vermillion has development programs in other clinical aspects of ovarian cancer as well as in peripheral arterial disease. Vermillion, Inc. is based in Fremont, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $109.454B 23.32
Intuitive Surgical (ISRG) United States $57.612B 50.39
Edwards Lifesciences (EW) United States $44.757B 43.56
IDEXX Laboratories (IDXX) United States $23.509B 58.98
Fresenius Medical Care AG KGaA (FMS) Germany $19.957B 13.22
Teleflex (TFX) United States $17.035B 36.16
Olympus (OCPNY) Japan $16.189B 121.13
SONOVA HOLDING (SONVY) Switzerland $14.665B 0.00
DexCom (DXCM) United States $14.456B 214.23
Hologic (HOLX) United States $13.317B 21.02
STERIS (STE) Ireland $12.870B 29.68
Sysmex ADR (SSMXY) Japan $12.420B 33.48
Varian Medical Systems (VAR) United States $9.773B 23.38
ABIOMED (ABMD) United States $8.715B 49.89
Masimo (MASI) United States $7.964B 48.32
SARTORIUS AG (SARTF) Germany $6.158B 54.71
Integra LifeSciences Holdings (IART) United States $5.135B 22.91
Penumbra (PEN) United States $5.054B 181.56
Elekta AB (EKTAY) Sweden $4.932B 39.35
Globus Medical (GMED) United States $4.827B 30.64
LivaNova (LIVN) United Kingdom $3.751B 28.60
Cantel Medical (CMD) United States $3.706B 37.59
Tandem Diabetes Care (TNDM) United States $3.350B 0.00
Wright Medical Group (WMGI) Netherlands $2.662B 233.44
Nihon Kohden (NHNKY) Japan $2.529B 25.45
Nevro (NVRO) United States $2.495B 0.00
Integer Holdings (ITGR) United States $2.473B 17.49
Glaukos (GKOS) United States $2.210B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.724B 31.97
Silk Road Medical (SILK) United States $1.230B 0.00
Veracyte (VCYT) United States $1.205B 0.00
OPKO Health (OPK) United States $1.170B 0.00
Natus Medical (NTUS) United States $1.031B 24.02
Accelerate Diagnostics (AXDX) United States $0.977B 0.00
CryoLife (CRY) United States $0.974B 92.79
ORTHOFIX MEDICAL INC (OFIX) United States $0.952B 29.89
Inogen (INGN) United States $0.940B 23.05
Tactile Systems Technology (TCMD) United States $0.924B 114.19
Luminex (LMNX) United States $0.921B 0.00
Pacific Biosciences Of California (PACB) United States $0.857B 0.00
Mesa Laboratories (MLAB) United States $0.852B 39.38
Quotient (QTNT) Switzerland $0.714B 0.00
AngioDynamics (ANGO) United States $0.699B 22.87
AxoGen (AXGN) United States $0.573B 0.00
Intersect ENT (XENT) United States $0.503B 0.00
OrthoPediatrics (KIDS) United States $0.464B 0.00
Si-Bone (SIBN) United States $0.457B 0.00
Fluidigm (FLDM) United States $0.443B 0.00
ViewRay (VRAY) United States $0.387B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.372B 14.29
GenMark Diagnostics (GNMK) United States $0.369B 0.00
Alphatec Holdings (ATEC) United States $0.343B 0.00
Sientra (SIEN) United States $0.316B 0.00
Semler Scientific (SMLR) United States $0.312B 52.75
Accuray (ARAY) United States $0.269B 0.00
IRadimed (IRMD) United States $0.239B 39.62
RTI Surgical (RTIX) United States $0.222B 33.33
SeaSpine Holdings (SPNE) United States $0.204B 0.00
Neuronetics (STIM) United States $0.178B 0.00
Stereotaxis (STXS) United States $0.167B 0.00
ConforMIS (CFMS) United States $0.126B 0.00
Sensus Healthcare (SRTS) United States $0.104B 0.00
Second Sight Medical Products (EYES) United States $0.097B 0.00
EDAP TMS S.A (EDAP) France $0.086B 0.00
Apollo Endosurgery (APEN) United States $0.069B 0.00
Ekso Bionics Holdings (EKSO) United States $0.063B 0.00
Spectral Diagnostics (EDTXF) Canada $0.062B 0.00
Helius Medical Technologies (HSDT) United States $0.052B 0.00
T2 Biosystems (TTOO) United States $0.036B 0.00
Nuvectra (NVTR) United States $0.028B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.027B 0.00
Restoration Robotics (HAIR) United States $0.026B 0.00
Ra Medical Systems (RMED) United States $0.025B 0.00
ReWalk Robotics (RWLK) Israel $0.025B 0.00
Neovasc (NVCN) Canada $0.022B 0.00
Bioanalytical Systems (BASI) United States $0.021B 0.00
DarioHealth (DRIO) Israel $0.018B 0.00
Lianluo Smart (LLIT) China $0.016B 0.00
OBALON THERPTCS (OBLN) United States $0.014B 0.00
Dynatronics (DYNT) United States $0.012B 0.00
Nanovibronix (NAOV) United States $0.012B 0.00
Avinger (AVGR) United States $0.010B 0.00
ENDRA Life Sciences (NDRA) United States $0.009B 0.00
Cesca Therapeutics (KOOL) United States $0.007B 0.00
Sunshine Heart Inc (CHFS) United States $0.006B 0.00
Allied Healthcare Products (AHPI) United States $0.006B 0.00
Viveve Medical (VIVE) United States $0.006B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.002B 0.00